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ABSTRACT 
Polyherbal traditional formulation Nishaakathakaadhi Kashayam elicit antihyperglycemic effects in 
streptozotocin induced hyperglycemic rats. Nishaakathakaadhi Kashayam 0.6 ml/kg, p.o. significantly 
reduced the fasted blood glucose level after 60 days of treatment in diabetic rats. The Kashayam also 
reduced serum cholesterol, triglycerides, LDL, VLDL, alanine transaminase, aspertate transaminase, 
alkaline phophatase and urea whereas increased HDL, albumin, protein and haemoglobin levels become 
normal after the treatment. Glycolytic enzyme showed a significant increases in Streptozotocin induced 
condition while a significant decrease were observed in levels of the gluconeogenic enzymes in 
Nishaakathakaadhi Kashayam treated diabetic rats. The Kashayam was non-significantly active with 
standard drug Glibenclamide (0.6 mg/kg, p.o.). The Kashayam has a positive effect on the 
histopathological changes of the pancreatic beta cells in Streptozotocin induced diabetic rats. The results 
suggest that Nishaakathakaadhi Kashayam possesses potential antihyperglycemic effect by regulating 
glucose homeostasis in streptozotocin induced diabetic rats. The scientific evidences to antidiabetic use 
suggest that administration of polyherbal formulation to rats, in a dosage used safely by humans, 
reduces the production of various diabetes causing biochemical parameters and concomitantly prevents 
the development of Type 2 (NIDDM) diabetes in established animal models. A combination of different 
herbals in NKK is used to get the enhanced desired activity. 
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INTRODUCTION
 Diabetes mellitus (DM) is world’s largest 
endocrine disease that occurs when the pancreas does not 
produce enough insulin, or when the body cannot 
effectively use the insulin it produces. In DM, gross 
abnormalities in glucose homeostasis, protein and lipid 
metabolism are observed. Decreased physical activity, 
increasing obesity, and changes in food consumption have 
been implicated in this epidemic. The World Health 
Organization predicts that the number of cases worldwide for 
diabetes is 250 million, 80% of people are living with diabetes 
and 5% of deaths are reported per year globally and this is 
likely to increase to 300 million or more by the year 2025[1,2]. 
In many parts of the world, traditional medicinal 
plants have been used for the treatment of diabetes. 
Satisfactory treatment to most of the severe DM is not 
available in conventional medicine and continuous intake 
of conventional medicine produces severe side effects. 
However, many herbal medicines play a vital role in the 
management of diabetes mellitus. There are many plants 
and polyherbal formulations used in traditional systems of 
medicine such as Ayurveda and Siddha as well as in 
folklore medicine from time immemorial to treat diabetes 
mellitus. The pharmacological evaluation using 
experimental animals also showed some level of 
antihyperglycemic activities in most of the traditional 
antihyperglycemic plants. In this study, antihyperglycemic 
effect of Nishaakathakaadhi Kashayam (NKK) was 
administered to Streptozotocin induced diabetic rats. 
Nishaakathakaadhi Kashayam, is a decoction popularly 
used in the treatment of pre-diabetes, diabetes and its 
complications. It is prepared by boiling coarse powders of 
rhizomes of Curcuma longa, root bark of Salacia oblonga, 
pericarp of Emblica officinalis, seeds of Strychnos 
potatorum, roots of Ixora coccinea, Vettiveria zizanoides, 
Aerva lanata and bark of Symplocos racemosa. 
MATERIALS AND METHODS 
Preparation of Kashayam  
 All eight raw materials were collected from Kerala 
Ayurveda, Athani and authenticated by the botanist from 
CARe Keralam Ltd. A voucher specimen is kept at the 
centre. The raw materials were air dried, pulverized, 
homogenized to fine powder and stored in airtight bottles. 
100 g each of all eight coarsely powdered raw materials 
were mixed thoroughly with 12.8 liter of distilled water. 
This was boiled and reduced to 3.2 liter. Then the 
decoction was filtered and again reduced to 1.6 liter. The 
decoction was allowed to cool and kept in airtight bottle in 
refrigerator[3].  
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Chemicals 
 Streptozotocin (STZ) was purchased from Sigma 
Aldrich chemical Co (St Louis, MO), USA. Commercial assay 
kits from Euro Diagnostic Ltd were used to measure the 
glucose, hepatic marker enzymes, bilirubin, total protein, 
albumin, urea, haemoglobin and lipid profiles. 
Animals  
 Adult male albino Sprague Dawley rats, weighing 
180-200 g were used. All animal experiments were 
approved by the Institutional Animal Ethics Committee, 
CARe Keralam Ltd and were maintained in accordance with 
the guidelines of the CPCSEA (1620/PO/c/12/CPCSEA). 
The animals were housed in polysulfonate individual 
ventilated cages in a room with a 12 h day-night cycle, 
temperature of 22  2C and humidity of 40-70%. During 
the experimental period, the animals were fed with a 
balanced commercial diet (Amrut animal feeds, Bangalure, 
India) [Composition of the diet: 5% fat, 21% protein, 55% 
nitrogen free extract and 4% fiber (w/w) with adequate 
mineral and vitamin contents) and water ad-libitum.  
Induction of diabetes mellitus, followed by NKK 
treatment 
 Experimental animals received a freshly prepared 
solution of STZ (45 mg/kg) in 0.1 M citrate buffer, pH 4.5, 
injected i.p in a volume of 1 ml/kg. Normal rats received 1 
ml citrate buffer as vehicle[4,5]. Two days after STZ 
administration, rats showing moderate diabetes with 
glycosuria and hyperglycemia (i.e., blood glucose levels of 
190-230 mg/dl) were used for the experiment. The 
animals were fasted overnight and blood samples were 
collected for blood glucose estimation. 
The rats were divided into three groups after the 
induction of STZ, normal control group used non diabetic 
rats. In this experiment six rats were used in each group. 
Group I : Normal Control (Vehicle treated) rats 
administrated single daily dose of vehicle 
for 60 days. 
Group II : Diabetic control (Vehicle treated) rats 
administered single daily dose of vehicle 
for 60 days. 
Group III : Diabetic rats administrated single daily 
dose of NKK (0.6 ml/kg p.o.) for 60 days. 
Group IV : Diabetic rats administrated single daily 
dose Glibenclamide (0.6 mg/kg p.o.) for 60 
days. 
Blood samples were drawn at ten days intervals 
till the end of the experimental period. At the end of the 
study, all rats were sacrificed by decapitation (euthanasia). 
Blood samples were collected and serum separated from the 
blood by centrifugation. Pancreas and liver were dissected, 
washed in ice-cold saline for biochemical analysis and 
histopathology. 
Biochemical estimation of enzyme activities 
 Hexokinase activity was assayed by the method of 
Brandstrup et al.[6], Glucose-6-phosphatase was assayed 
according to the method of Koida and Oda[7] and Fructose-
1,6-bisphosphatase was assayed by the method of Gancedo 
and Gancedo[8]. 
Statistical analysis 
 All data were expressed as mean  SD. The 
statistical significance was evaluated by one-way ANOVA 
using SPSS version 12 (SPSS, Cary, NC, USA) and the 
individual comparison were obtained by Duncan’s Multiple 
Range Test (DMRT). A value of p<0.05 was considered to 
indicate a significant difference between groups. Values 
sharing a common superscript do not differ significantly 
with each other at p<0.05. 
RESULTS AND DISCUSSION 
 Table 1 shows beginning to end the fasting blood 
glucose concentration of normal control rats was 86.2±6.1 
to 89.0±10.6 mg/dl. In the present study, Streptozotocin 
induced rats showed significant increase in blood glucose 
level and a single dose of Streptozotocin in rates exhibited 
characteristic signs of diabetic. NKK significantly reduced 
the blood glucose level from 221.7±18.8 to 118.0±5.6 on 
60 days treatment period. Glibenclamide treated group 
and NKK treated group showed no significant difference 
between the groups. 
Table 1.Effect of NKK in blood glucose level changes in STZ induced Diabetic rats 
Groups 
Initial 
Glucose (mg/dl) 
10th day 
(mg/dl) 
20th day 
(mg/dl) 
30th day 
(mg/dl) 
40th day 
(mg/dl) 
50th day 
(mg/dl) 
61st day 
(mg/dl) 
Normal control 86.2±6.1a 91.3±8.8a 98.6±14.4a 98.7±11.9a 99.2±11.8a 91.4±5.1a 89.0±10.6a 
Diabetic control 214.3±28.2b 216.4±20.6b 212.3±18.2b 220.4±16.0b 216.0±21.2b 220.9±8.6b 215.4±4.3b 
NKK 221.7±18.8b 147.8±15.1c 129.8±18.2c 123.0±9.6c 124.2±6.2c 118.4±7.2c 118.0±5.6c 
Glibenclamide 190.7±18.5b 139.4±14.6c 137.5±11.4c 120.6±15.3c 115.2±12.1c 104.6±11.3ac 102.4±6.1ac 
NKK – Nishaakathakaadhi Kashayam 
 Values are mean ± SD for 6 rats in each group. a-c In 
each column, means with different superscript letter differ 
significantly at p<0.05 (DMRT). 
The table 2 shows the level of serum lipid profiles 
in normal and treated rats. The levels of triglycerides (TG) 
and total cholesterol (TC) were significantly increased in 
diabetic control rats. Administration of NKK and 
Glibenclamide for 60 days to diabetic rats decreased the 
TG and TC levels. The effect of NKK was predominant than 
that of Glibenclamide.  
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Table 2. Effect of NKK in serum lipid profiles level changes in STZ induced d iabetic rats 
Groups 
Total Cholesterol 
(mg/dl) 
Triglycerides 
(mg/dl) 
HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl) 
Normal control 78.1±9.5a 43.8±7.8 a 37.7±4.6 a 31.5±5.6 a 8.8±3.6 a 
Diabetic control 120.7±11.1b 51.9±5.8 b 26.5±6.4 b 83.9±6.8 b 10.4±1.2 b 
NKK 78.3±5.0 a 38.9±5.9 a 34.7±10.7 a 35.2±3.2 a 7.8±2.0 a 
Glibenclamide 80.0±3.2 a 50.6±5.4 b 35.2±10.0 a 34.1±3.5 a 10.1±1.1 b 
NKK – Nishaakathakaadhi Kashayam. 
Values are mean ± SD for 6 rats in each group. a-b In each column, means with different superscript letter differ significantly 
at p<0.05 (DMRT). 
The effects of administering NKK to diabetic rats on serum enzymes aspartate amino transferase (AST), alanine 
amino transferase (ALT) and alkaline phosphatase (ALP) are given in Table 3. STZ administration increased liver function 
biomarkers such as ALP, AST and ALP significantly in comparison with normal control rats. The activities of serum 
enzymes like AST (125.4±9.7), ALT (66.6±7.6) and ALP (223.7±20.7) were significantly increased in the diabetic rats when 
compared to those of normal control rats. But the activities of serum AST (97.5±7.1), ALT (52.7±8.8) and ALP (194.4±12.7) 
were significantly decreased in diabetic rats treated with NKK when compared to those of diabetic rats. In addition, the 
administration of Glibenclamide at the dose of 0.6 mg/kg b.w. also significantly reduced AST, ALT and ALP activities in 
serum of diabetic rats.  
Table 3: Effect of NKK in serum liver marker enzymes, protein, albumin, hemoglobin and urea level changes in 
STZ induced Diabetic rats 
Groups AST (IU/L) ALT (IU/L) ALP (IU/L) 
Albumin 
(g/dl) 
Protein 
(g/dl) 
Urea 
(mg/dl) 
Hb 
(g/dl) 
Normal control 100.1±12.5a 58.6±7.7a 182.6±17.7a 3.1±0.5a 5.1±1.1a 37.0±5.4a 15.5±2.0a 
Diabetic control 125.4±9.7b 66.6±7.6 b 223.7±20.7b 2.1±0.3 b 4.0±0.7b 44.7±5.1 b 6.4±0.5 b 
NKK 97.5±7.1a 52.7±8.8a 194.4±12.7a 3.9±0.4 c 5.6±1.0a 32.6±6.9a,c 13.4±0.9a 
Glibenclamide 106.8±11.9a 56.7±10.8a 193.4±18.0a 4.0±0.1 c 5.7±0.3a 29.6±3.4 c 14.2±0.4a 
NKK – Nishaakathakaadhi Kashayam. 
Values are mean ± SD for 6 rats in each group. a-c In each column, means with different superscript letter differ significantly 
at p<0.05 (DMRT). 
The serum albumin, protein and urea levels are increased whereas haemoglobin level decreased in STZ induced 
diabetic control animals. NKK (0.6 ml/kg) 60 days treated in diabetic rats to normalise serum albumin, protein, urea and 
haemoglobin near to normal level. The Glibenclamide and NKK group rats no significantly differ between the groups. 
There is significant difference in the body weight, food and water intake of DM with that of NKK. Hence it is 
concluded that NKK is having efficacy in regulating the bodyweight. Animals maintained a remarkable, stable body weight 
(Fig. 1). 
 
Fig.1: Effect of NKK in body weight changes in STZ induced diabetic rats 
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Table 4 depicts the activities of carbohydrate metabolizing enzymes in liver of normal and treated rats. The 
activities of enzyme hexokinase was significantly decreased whereas the activities of gluconeogenic enzymes: glucose-6-
phosphatase and fructose-1,6- bisphosphatase were significantly increased in diabetic control rats. NKK administration to 
diabetic rats reversed the above changes in a significant manner when compared to diabetic control rats. Histopathological 
evaluation of rat pancreas by H and E staining showed pancreas with normal acini and also many islet cell clusters in 
control groups, acinar cells in clusters surrounded by fat globules diabetic group and NKK group and glibenclamide group 
showed pancreatic acinar cells with normal morphology separated by fat lobules (Fig. 2).  
 
Table 4. Effect of NKK in liver glucose metabolic enzymes level changes in STZ induced Diabetic rats 
Groups 
fru-1,6 bi p ase  
(Units1/ mg protein) 
Glu 6 p ase  
(Units
2
/ mg protein) 
Hexokinase 
(Units
3
/g protein) 
Normal control 0.20.05 a 0.150.01 a 141.33.1 a 
Diabetic control 0.50.04 b 0.270.02 b 105.59.2 b 
NKK 0.23±0.03 a 0.17±0.03 a 136.2±8.3 a 
Glibenclamide 0.250.01 a 0.160.01 a 138.87.4 a 
NKK – Nishaakathakaadhi Kashayam  
Values are mean ± SD for 6 rats in each group. a-b In each column, means with different superscript letter differ significantly 
at p<0.05 (DMRT) 
Unit 1moles of inorganic phosphorus liberated/hour/mg protein 
Unit 2moles of inorganic phosphorus liberated/min/mg protein
Unit 3moles of glucose phosphorylated/min/g protein 
 
 
 Fig. 2: Histology of pancreatic sections stained 
with haematoxylin and eosin (A) Normal rat pancreas 
section shows pancreas with normal acini & also many 
islet cell clusters; (B) Diabetic rat pancreas section shows 
fat lobules, islet cells are shrinkage & few congested 
vessels; (C) NKK group pancreas section shows pancreatic 
tissue with normal acini and lobules of mature adipocytes 
are seen; (D) Glibenclamide group pancreas section shows 
pancreatic acinar cells in clusters surrounded by fat 
globules. 
Diabetes mellitus (Type II) comprises a 
heterogeneous group of hyperglycemic disorders 
characterized by loss of glucose homeostasis and 
disturbances of carbohydrate and lipid metabolism. 
Patients with diabetes are at increased risk of 
atherosclerosis and its clinical effects: coronary, renal, 
peripheral vascular and cerebrovascular diseases. 
Concurrently, the most common cause of death in persons 
with diabetes is myocardial infarction. The pathogenesis, 
progression and epidemiology of atherosclerotic disease 
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are distinct in patients with diabetes. Several therapeutic 
agents are used for solving this problem. Streptozotocin is 
a frequently used drug that exerts a diabetogenic effect 
through a specific damage of the pancreatic Beta-cells, 
mimicking type 1 diabetes mellitus [9,10]. Blood glucose 
needs to be individually tailored as part of a 
comprehensive cardiovascular risk management strategy. 
Chronic administration of NKK to STZ-induced diabetic 
rats showed significant and consistent decrease in fasting 
blood glucose levels at different time intervals throughout 
the period of study as compared to the vehicle treated 
diabetic controls, indicating its potent antidiabetic activity. 
Since lipid abnormalities accompanied by 
premature atherosclerosis are the major cause of 
cardiovascular diseases in diabetic patients ideal 
treatment should have a effect on lipid profile. 
Cardiovascular diseases are listed as the cause of death in 
65% people suffering from diabetes[11]. NKK not only 
lowered the TC, TG, VLDL and LDL levels but also 
enhanced the cardio protective lipid HDL in diabetic rats, 
after 60 days of treatment. Several studies have shown 
that an increase in HDL-cholesterol is associated with a 
decrease in coronary risk[12] and most of the drugs that 
decrease total cholesterol also decrease HDL 
cholesterol[13]. In the present study NKK not only 
decreased the total cholesterol but also enhanced HDL-
cholesterol significantly. 
In the present study the activities of AST, ALT and 
ALP in serum were altered in diabetic animals. The 
changes in the levels of AST, ALT and ALP are directly 
related to changes in metabolism in which the enzymes are 
involved. The increased activities of transaminases, which 
are active in the absence of insulin due to the availability of 
amino acids in the blood of demand, are also responsible 
for the increased gluconeogenesis and ketogenesis[14]. AST 
and ALT levels also act as an indicator of liver function. 
Hence restoration of normal level of these enzymes 
indicates the normal functioning of liver. Increased 
activities of serum ALP have been observed in STZ diabetic 
rats. STZ treated diabetes caused lipid peroxide mediated 
tissue damage in the pancrease, liver, kidney, and heart. 
The increase in the levels of these enzymes in diabetes 
may be as a result of the leaking out from the tissues and 
then migrating into the blood stream. Diabetes and 
hyperlipidaemia also cause cell damage by altering the cell 
membrane architecture, which results in enhanced activity 
of ALP in diabetic rats. The cell damage might be reverted 
NKK and glibenclamide treated groups and this may leads 
to the decreased activity of ALT, AST and ALP. Therefore, 
the present study clearly indicates that NKK possess 
hypoglycaemic and hypolipidaemic activities in STZ 
induced diabetic rats. 
Polyphagia, polydipsia, polyuria, increased water 
intake and weight loss are established classical symptoms 
and signs of diabetes mellitus. The decrease in body 
weight in diabetic rats clearly showed a loss or 
degradation of structural proteins. Individuals with 
untreated diabetes mellitus also experience significant 
weight loss due to the inability of cells to utilize glucose for 
energy production. 
Hexokinase is the prime enzyme catalysing 
glucose phosphorylation. Impairment of hexokinase 
activity suggests the impaired oxidation of glucose via 
glycolysis leading to its accumulation resulting in 
hyperglycemia. Insulin influences the intracellular 
utilization of glucose in a number of ways. Insulin 
increases hepatic glycolysis by increasing the activity and 
amount of several key enzymes including glucokinase and 
phosphofructokinase[15]. Hexokinase is universally present 
in cells of all types. Hexokinase catalyses the conversion of 
glucose to glucose 6-phosphate and plays a central role in 
the maintenance of glucose homeostasis[16-18]. In our 
present study hexokinase activity was decreased in 
diabetic control rats. Decrease in hepatic hexokinase has 
been reported in STZ diabetic rats. Administration of NKK 
to diabetic rats enhanced the hexokinase activity and 
suggests greater uptake of glucose from blood by liver cells 
and increased glycolysis. In addition, NKK may regulate 
the activity of hexokinase by maintaining the critical levels 
of glucose-6-phosphate needed to be catabolized to 
produce ATP and NAD. 
Activation of gluconeogenic enzymes is due to 
state of insulin deficiency since under normal condition 
insulin functions as a suppressor of gluconeogenic 
enzymes. Administration of NKK significantly depressed 
the activities of gluconeogenic enzymes in diabetic rats. 
The effect of NKK may be primarily modulating and 
regulating the activities of the two gluconeogenic enzymes, 
either through regulation of cAMP or any other metabolite 
activation/inhibition of glycolysis/gluconeogenesis. The 
reduction in the activities of gluconeogenic enzymes can 
result in the decreased concentration of glucose in 
blood[19,20]. 
CONCLUSION 
The findings provide scientific evidences to 
antidiabetic use of a traditional formulation and suggest 
that administration of polyherbal formulation to rats, in a 
dosage used safely by humans, reduces the production of 
various diabetes causing biochemical parameters and 
concomitantly prevents the development of Type 2 
(NIDDM) diabetes in established animal models. 
A combination of different herbals in NKK is used 
to get the enhanced desired activity and eliminate 
unwanted side effects. In the present study, NKK produced 
significant antidiabetic activity in experimental animals 
and is also effective in case of glucose metabolic enzymes. 
Hence NKK can be effectively used in the treatment of 
diabetes mellitus. However the studies on diabetic patients 
are under progress to establish its effectiveness in human 
volunteers. 
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